- IRB regulations require at least annual monitoring of all non-exempt human subject research projects which employ more than minimal risk. The IRB may choose to prescribe more frequent monitoring based on risk level.
- Protocols Requiring Continuing Reivew: Prior to the expiration date of your protocol approval, you will be required to complete an annual Continuing Review Form to provide the IRB with a brief summary of the project. The PI can select whether this project is complete or can request an extension on this form. Due to the Revised Common Rule, most expedited protocols will no longer require continuing review. Upon your anniversary date, your protocol will be transitioned to the New Rule. If your project still requires continuing oversight, you will be notified in writing. Full Board Protocols still require continuing review.
- An extension request must be approved by the IRB before continuing the study beyond the project approval period. The IRB requests that these continuing review forms be submitted at minimum 14 days prior to protocol expiration. Submitting an extension request in sufficient time is the responsibility of the PI.
- If the protocol expires, all data collection must stop and a new application must be submitted to the IRB for review in order to continue the human subjects research.
- All Exempt Protocols: Per federal regulations and to help reduce administrative burden, researchers will receive an annual email notification of their ongoing responsibilities to the IRB, and request that PI's update the IRB on the status of their protocol. This includes, but is not limited to: 1) open/closed status, 2) recruitment and data collection, 3) anticipated* changes, 4) adverse events/problems.
*As always, any modifications to a protocol must be submitted to the IRB prior to carrying out said changes.
Exempt protocols automatically expire after 5 years, at which time the PI will be required to submit a new protocol application if they wish to continue the study.